Skye Bioscience, Inc. (SKYE)
2.17
-0.07
(-3.12%)
USD |
NASDAQ |
Aug 24, 16:00
2.20
+0.03
(+1.38%)
After-Hours: 20:00
Skye Bioscience Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 29, 2026 | 2.614 |
| June 26, 2026 | 2.650 |
| June 25, 2026 | 2.761 |
| June 24, 2026 | 2.647 |
| June 23, 2026 | 2.728 |
| June 22, 2026 | 2.763 |
| June 18, 2026 | 2.757 |
| June 17, 2026 | 2.773 |
| June 16, 2026 | 2.800 |
| June 15, 2026 | 2.844 |
| June 12, 2026 | 3.068 |
| June 11, 2026 | 3.116 |
| June 10, 2026 | 3.040 |
| June 09, 2026 | 2.927 |
| June 08, 2026 | 3.001 |
| June 05, 2026 | 2.858 |
| June 04, 2026 | 3.020 |
| June 03, 2026 | 3.002 |
| June 02, 2026 | 2.782 |
| June 01, 2026 | 2.962 |
| May 29, 2026 | 3.022 |
| May 28, 2026 | 3.313 |
| May 27, 2026 | 3.229 |
| May 26, 2026 | 3.204 |
| May 22, 2026 | 3.232 |
| Date | Value |
|---|---|
| May 21, 2026 | 2.786 |
| May 20, 2026 | 2.998 |
| May 19, 2026 | 2.827 |
| May 18, 2026 | 3.031 |
| May 15, 2026 | 3.171 |
| May 14, 2026 | 3.396 |
| May 13, 2026 | 3.195 |
| May 12, 2026 | 3.171 |
| May 11, 2026 | 3.430 |
| May 08, 2026 | 3.363 |
| May 07, 2026 | 3.502 |
| May 06, 2026 | 3.316 |
| May 05, 2026 | 3.419 |
| May 04, 2026 | 3.391 |
| May 01, 2026 | 3.210 |
| April 30, 2026 | 3.426 |
| April 29, 2026 | 3.485 |
| April 28, 2026 | 3.625 |
| April 27, 2026 | 4.132 |
| April 24, 2026 | 3.781 |
| April 23, 2026 | 3.503 |
| April 22, 2026 | 3.508 |
| April 21, 2026 | 3.216 |
| April 20, 2026 | 3.054 |
| April 17, 2026 | 3.075 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Regeneron Pharmaceuticals, Inc. | 2.702 |
| Viking Therapeutics, Inc. | 9.494 |
| ACADIA Pharmaceuticals, Inc. | 3.906 |
| Alnylam Pharmaceuticals, Inc. | 23.31 |
| Savara, Inc. | 7.949 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0112 |
| Price | 2.17 |
| Earnings Yield | -469.1% |
| Market Cap | 76.26M |
| PEGY Ratio | -0.0112 |